Hemerion Therapeutics
PrivateLast Round
Series A
May 22, 2025
Est. Valuation
$32.94M
Total Funding Raised
$17.9M
Company Overview
Hemerion Therapeutics is a biotechnology company that develops therapeutic solutions combining photosensitizing molecules and laser light technologies to treat resistant tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hemerion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Hemerion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 22, 2025 | ||||
| Series A | Mar 1, 2025 | ||||
| Seed | Apr 14, 2022 |
Key People
Founding team and executive leadership
Hemerion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nord France Amorquage | Series A |
| Bpifrance | Series A, Seed |
| European Regional Development Fund | Series A |
| FIRA Nord-Est 2 | Series A |
| Finovam Gestion | Series A, Seed |
| Bpifrance | Series A |
| Capital Cell | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2025
$7M round completed.
Hemerion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hemerion Therapeutics's valuation, stock price, and market status.
